West Virginia College of Law professor S. Sean Tu recently published new scholarship in Chest, the journal of the American College of Chest Physicians. The article is titled "Patenting strategies on inhaler delivery devices." Professor Tu co-authored the article with Brandon J. Demkowicz, Aaron S. Kesselheim, M.D., J.D., M.P.H. and William B. Feldman, M.D., D.Phil., M.P.H., colleagues at the Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School, and Michael A. Carrier, J.D. of Rutgers Law School.  

The article pre-print was published online on February 25, 2023 and will subsequently appear in volume 163 of the journal later in 2023.

West Virginia Unviversity College of Law Professor Sean Tu will receive a research grant from the National Institute of Health Care Management in 2023-2024. NIHCM awards grants to those who initiate work that will "advance evidence on a broad range of factors that contribute to rising health care costs and ongoing health care disparities."

Professor Tu's project is called "Improving Competitive Drug Markets by Reviewing Patents." He will be joined on the project by Aaron S. Kesselheim of Harvard University and Victor van de Wiele of the University of Cambridge.

West Virginia University College of Law Professor Sean Tu was recently interviewed by MedPage Today. In the interview, Professor Tu discusses the methods that pharmaceutical companies use to monopolize the prescription drug market such as evergreening, patent thicketing, and product topping.  The interview was published online on February 3, 2023.

Professor Tu has recently published on the topic in the New England Journal of Medicine: A “Method of Use” to Prevent Generic and Biosimilar Market Entry. This article was published online by the journal on January 25, 2023 in print in volume 388.

West Virginia College of Law professor S. Sean Tu recently published new scholarship in the New England Journal of Medicine. The article is titled A "Method of Use" to Prevent Generic and Biosimilar Market Entry. Professor Tu co-authored the article with Ameet Sarpatwari, Ph.D., J.D., a colleague at the Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School where Professor Tu is a visiting professor.  It was published online by the journal on January 25, 2023 and will subsequently appear in print in volume 388 on February 9, 2023.

Find more of Professor Tu's scholarship on SSRN.

West Virginia College of Law professor S. Sean Tu recently published new scholarship in  JAMA Internal Medicine. The article, titled "Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings" is co-authored by Professor Tu with researchers at Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School where Professor Tu is a visiting professor.  It was published online by the journal on November 28, 2022.

The journal editors simultaneously published an Editor's Note highlighting the importance and impact of the issues addressed by Professor Tu and co-authors in their article: "Savings Associated With “Skinny Label” Biosimilars."